Revenue fell 52% as Serko's pandemic losses widened to a $29.0m PBT loss

Net profit followed to a $29.4m loss. This is a demand-destruction story, not a like-for-like distortion: Serko's own commentary describes booking volumes falling to as little as 11% of prior-year levels before recovering later in the year.

Operating cash flow swung to an $18.0m outflow, and cash fell to $34.9m from $42.4m despite the $67.5m capital raise completed in October 2020 that was meant to fund the business through the downturn. Total equity rose 60.7% to $102.5m purely on that raise, not on trading performance, so the balance-sheet strength reflects financing, not operating recovery.

The $18.0m operating outflow against $34.9m of cash means Serko consumed roughly half the capital raise's benefit in a single year; if burn persists near this rate, the raise buys limited additional runway rather than a cushion for a multi-year recovery.

Debtor days spiked to an unprecedented 91.3 days versus a historical average of 27.8 days, even though trade debtors in dollar terms actually fell slightly to $2.6m from $3.8m. This is a denominator effect from the revenue collapse rather than a genuine collections problem, but it means days-based working-capital ratios cannot be read cleanly this period.

Capex intensity fell sharply, with capex at 8.3% of revenue versus 46.2% in the prior year, implying a large pullback in capitalized product development. This matters because reduced investment during the downturn may have protected cash in the short term but raises questions about product pipeline strength heading into any demand recovery.

The half-year context shows H1 revenue of $5.1m was 40.7% of the full-year total, while H1 NPAT loss was only 34.4% of the full-year loss, meaning the second half carried a larger share of the annual loss even as management described booking volumes improving toward year end. That combination, improving volumes but a heavier loss weighting in the second half, suggests continued cost retention (management explicitly says it chose to retain resources and capacity for recovery) rather than an operating turn, and it is not yet supported by the cash or margin trajectory.

The near-zero PBT margin and NPAT margin, both flagged as sitting at the upper edge of Serko's recent range, reflect an unusually small revenue base rather than genuine profitability strength, so these should not be read as a margin improvement. The effective tax rate of 0.0% is above the historical average of -4.2%, but with pre-tax losses this is a mechanical outcome of the tax position rather than a distortion worth separate scrutiny. Cash quality is weak: the operating cash outflow was funded by the prior capital raise rather than by internally generated cash, and gross borrowings remain negligible at under $0.1m, so the company carries no debt-service risk but also no cash-flow cushion of its own making.

This briefing cannot assess whether the underlying cost base is scaled appropriately for a sustained recovery, since no segment-level margin or unit-economics detail was provided.